We recently reported that an increase in cellular O-GlcNAcylation, which could be endorsed by an inhibition OGA or alternatively an activation of OGT, sensitizes MCL cells to BTZ-induced apoptosis and reverses their apoptosis resistance via the stabilization of truncated Bid (tBid) [31]. The gene discussed is CASC3; the disease is mantle cell lymphoma.